Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
posted on
Oct 15, 2024 12:11PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
it seems pathetic on Zenith management part that everytime there is some buying interest in ZHCLF on the expert market that they knock the price down to .00001 with a few hundred shares, it really doesn;t make a difference what the share price is whether .00001 or .15 Management should spend time finding a new CEO and chairman of the BOD to replace DM so that an actual BP deal can get done as it looks like the same old waiting game with DM at the helm., No deals He just won't get the hint. Prove me wrong DM